These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37475642)

  • 41. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals.
    Fukuda T; Hamaguchi M; Kojima T; Hashimoto Y; Ohbora A; Kato T; Nakamura N; Fukui M
    Liver Int; 2016 Feb; 36(2):275-83. PubMed ID: 26176710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults.
    Jeong S; Oh YH; Choi S; Chang J; Kim SM; Son JS; Lee G; Ahn JC; Lee DH; Koo BK; Kim W; Park SM
    Clin Mol Hepatol; 2022 Jul; 28(3):510-521. PubMed ID: 35299291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study.
    Kim KS; Hong S; Ahn HY; Park CY
    Diabetes Metab J; 2023 Mar; 47(2):220-231. PubMed ID: 36631994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study.
    Jung CY; Koh HB; Park KH; Joo YS; Kim HW; Ahn SH; Park JT; Kim SU
    Diabetes Metab; 2022 Jul; 48(4):101344. PubMed ID: 35346856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study.
    Sinn DH; Kang D; Chang Y; Ryu S; Cho SJ; Paik SW; Song YB; Pastor-Barriuso R; Guallar E; Cho J; Gwak GY
    J Gastroenterol Hepatol; 2020 May; 35(5):833-839. PubMed ID: 31512278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up.
    Fracanzani AL; Tiraboschi S; Pisano G; Consonni D; Baragetti A; Bertelli C; Norata D; Valenti L; Grigore L; Porzio M; Catapano A; Fargion S
    Atherosclerosis; 2016 Mar; 246():208-13. PubMed ID: 26803429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonalcoholic Fatty Liver Disease and Risk of Dementia: A Population-Based Cohort Study.
    Shang Y; Widman L; Hagström H
    Neurology; 2022 Aug; 99(6):e574-e582. PubMed ID: 35831178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term prognosis of patients with alcohol-related liver disease or non-alcoholic fatty liver disease according to metabolic syndrome or alcohol use.
    Decraecker M; Dutartre D; Hiriart JB; Irles-Depé M; Marraud des Grottes H; Chermak F; Foucher J; Delamarre A; de Ledinghen V
    Liver Int; 2022 Feb; 42(2):350-362. PubMed ID: 34679242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.
    Kanwal F; Kramer JR; Mapakshi S; Natarajan Y; Chayanupatkul M; Richardson PA; Li L; Desiderio R; Thrift AP; Asch SM; Chu J; El-Serag HB
    Gastroenterology; 2018 Dec; 155(6):1828-1837.e2. PubMed ID: 30144434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels.
    Zhu W; Liang A; Shi P; Yuan S; Zhu Y; Fu J; Zheng T; Wen Z; Wu X
    BMC Gastroenterol; 2022 Apr; 22(1):196. PubMed ID: 35448944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NAFLD does not increase the risk of incident dementia: A prospective study and meta-analysis.
    Huang H; Liu Z; Xie J; Xu C
    J Psychiatr Res; 2023 May; 161():435-440. PubMed ID: 37043979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between nonalcoholic fatty liver disease and colorectal cancer: A population-based study.
    Wu PH; Chung CH; Wang YH; Hu JM; Chien WC; Cheng YC
    Medicine (Baltimore); 2023 May; 102(21):e33867. PubMed ID: 37233422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up.
    Holmer M; Ekstedt M; Nasr P; Zenlander R; Wester A; Tavaglione F; Romeo S; Kechagias S; Stål P; Hagström H
    Liver Int; 2022 Dec; 42(12):2769-2780. PubMed ID: 36166317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.
    Younossi ZM; Stepanova M; Ong J; Yilmaz Y; Duseja A; Eguchi Y; El Kassas M; Castellanos-Fernandez M; George J; Jacobson IM; Bugianesi E; Wong VW; Arrese M; de Ledinghen V; Romero-Gomez M; Mendez-Sanchez N; Ahmed A; Wong R; Papatheodoridis G; Serfaty L; Younossi I; Nader F; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1625-1633.e1. PubMed ID: 30476585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
    Bessissow T; Le NH; Rollet K; Afif W; Bitton A; Sebastiani G
    Inflamm Bowel Dis; 2016 Aug; 22(8):1937-44. PubMed ID: 27379445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Not only baseline but cumulative exposure of remnant cholesterol predicts the development of nonalcoholic fatty liver disease: a cohort study.
    Liu L; Wang C; Hu Z; Deng S; Yang S; Zhu X; Deng Y; Wang Y
    Environ Health Prev Med; 2024; 29():5. PubMed ID: 38325840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men.
    Hwang YC; Ahn HY; Park SW; Park CY
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1131-1137.e5. PubMed ID: 29158157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy.
    Wong VW; Wong GL; Yeung DK; Lau TK; Chan CK; Chim AM; Abrigo JM; Chan RS; Woo J; Tse YK; Chu WC; Chan HL
    J Hepatol; 2015 Jan; 62(1):182-9. PubMed ID: 25195550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study.
    Lee KW; Bang KB; Rhee EJ; Kwon HJ; Lee MY; Cho YK
    Clin Mol Hepatol; 2015 Dec; 21(4):372-8. PubMed ID: 26770926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.